Efficacy of nivolumab in pre-treated non-small-cell lung cancer patients harbouring KRAS mutations

F. Passiglia, F. Cappuzzo, O. Alabiso, A.C. Bettini, P. Bidoli, R. Chiari, C. Defferrari, A. Delmonte, G. Finocchiaro, G. Francini, F. Gelsomino, D. Giannarelli, M. Giordano, A. Illiano, L. Livi, O. Martelli, C. Natoli, G. Puppo, E. Ricevuto, E. RocaD. Turci, D. Galetta

Research output: Contribution to journalArticle

Original languageItalian
Pages (from-to)57-62
Number of pages6
JournalBritish Journal of Cancer
Volume120
Issue number1
DOIs
Publication statusPublished - 2019

Cite this

Passiglia, F., Cappuzzo, F., Alabiso, O., Bettini, A. C., Bidoli, P., Chiari, R., Defferrari, C., Delmonte, A., Finocchiaro, G., Francini, G., Gelsomino, F., Giannarelli, D., Giordano, M., Illiano, A., Livi, L., Martelli, O., Natoli, C., Puppo, G., Ricevuto, E., ... Galetta, D. (2019). Efficacy of nivolumab in pre-treated non-small-cell lung cancer patients harbouring KRAS mutations. British Journal of Cancer, 120(1), 57-62. https://doi.org/10.1038/s41416-018-0234-3